HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 8, 1996, Pages 628-633

  Thonnard, Joëlle ^a   Philippe, Marianne ^a   Cao, Ming Yu ^a,c   Deggouj, Naïma ^a,c   Osselaer, Jean Claude ^a,b   Gersdorff, Michel ^a,c   Tomasi, Jean Paul ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

autoimmune inner ear disease; hearing loss; HLA class II; polymerase chain reaction; restriction fragment length polymorphism; reverse dot blot; sequence specific oligonucleotide

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR3 ANTIGEN;

ALLELE; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOT HYBRIDIZATION; FEMALE; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; INNER EAR DISEASE; MALE; NUCLEOTIDE SEQUENCE; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 9444280138     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500808     Document Type: Article

References (27)

1. Svejgaard A, Platz P, Ryder LP, HLA and disease 1982. A survey. Immunol Rev 1983;70:193-218.
2. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope 1984;94:758-67.
3. Harris JP, Sharp PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990;100:516-24.
4. Joliat T, Seyer J, Bernstein J, et al. Antibodies against a 30 kilodalton cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases. Ann Otol Rhinol Laryngol 1992;101:1000-6.
5. Cao MY, Gersdorff M, Deggouj N, Tomasi J-P. The localization and specificity of guinea pig inner ear antigenic epitopes. J Laryngol Otol 1995;109:20-4.
6. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
7. Bowman CA, Nelson RA. Human leukocyte antigens in autoimmune sensorineural hearing loss. Laryngoscope 1987;97:7-9.
8. Bernstein JM, Shanahan T, Yoo TJ, Ye XJ. HLA antigens and inner ear disease. In: McCabe BF, Veldman JE, Mogi G, eds. Immunobiology in otology, rhinology and laryngology. Amsterdam, the Netherlands: Kugler Publications, 1992:3-11.
9. Wallace DM. General methods for isolating and characterizing nucleic acid. In: Berger SL, Kimmel AR, eds. Guide to molecular cloning. San Diego, Calif: Academic Press, 1987:33-48. (Abelson JN, Simon MI, eds. Methods in enzymology: vol 152.)
10. Buyse I, Decorte R, Baens M, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993;41:1-14.
11. Sengar DPS, Goldstein R. Comprehensive typing of DQB1 alleles by PCR-RFLP. Tissue Antigens 1994;43:242-8.
12. Sengar DPS, Goldstein R, Toye B, Hampton N. Comprehensive typing of DR52 (DRB3)-associated DRB1 and DRB3 alleles by PCR-RFLP. Tissue Antigens 1994;43:286-94.
13. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992;39:187-202.
14. Sengar DPS, Goldstein R. Typing of DRB3*, DRB4* and DRB5* alleles by PCR-RFLP [Abstract]. Hum Immunol 1993; 37(suppl 1):128.
15. Vaerman JL, Moureau P, Larondelle Y, Martiat P, Philippe M. Prediction of oligodeoxyribonucleotides eluting salt conditions on anion exchange column. Nucleic Acids Res 1992;20:3522.
16. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955;20:309-11.
17. Tiwari JL, Terasaki PI. HLA and disease associations. New York, NY: Springer-Verlag. 1985:19-27.
18. Todd JA, Bell JI, McDevitt HO. HAL-DQB contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599-604.
19. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQβ chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 1988;85:8111-5.
20. Ronningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E. The amino acid at position 57 of the HLA-DQβ chain and susceptibility to developinsulin-dependent diabetes mellitus. Hum Immunol 1989;26:221-5.
21. Begovich AB, Bugawan TL, Nepom SB, Klitz W, Nepom GT, Erlich HA. A specific HLA-DPB allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Proc Natl Acad Sci USA 1989;86:9489-93.
22. Bugawan TL, Angelini G, Larrick L, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DPβ allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 1989;339:470-3.
23. Howell WM, Evans PR, Devereux SA, Sage DA, Smith JL, Haegert DG. Absence of strong HLA-DR/DQ-DP linkage disequilibrium in the British and French Canadian caucasoid populations. Eur J Immunogen 1993;20:363-71.
24. Wilson WR,Veltri RW, Laird N, Sprinkle PM. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983;91:653-8.
25. Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA 1990;264:2093-6.
26. Cotter CS, Singleton GT, Corman LC. Immune-mediated inner ear disease and parvovirus B19. Laryngoscope 1994;104:1235-9.
27. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.